{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:04:48Z","timestamp":1778220288814,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health (NIH)\/National Institute of Mental Health","award":["R21MH102646"],"award-info":[{"award-number":["R21MH102646"]}]},{"name":"NIH\/NIMH","award":["1F31MH103969"],"award-info":[{"award-number":["1F31MH103969"]}]},{"name":"NIH\/NIMH","award":["R34MH099318"],"award-info":[{"award-number":["R34MH099318"]}]},{"name":"NIH\/NIMH","award":["R34MH086668"],"award-info":[{"award-number":["R34MH086668"]}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["Grant No. K24 DA030443"],"award-info":[{"award-number":["Grant No. K24 DA030443"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NIMH","award":["5R34MH099309-02"],"award-info":[{"award-number":["5R34MH099309-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.biopsych.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T02:31:43Z","timestamp":1443234703000},"page":"274-283","source":"Crossref","is-referenced-by-count":60,"title":["Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions"],"prefix":"10.1016","volume":"80","author":[{"given":"Michael W.","family":"Otto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Alexandra","family":"Kredlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper A.J.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan G.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Tolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianne A.","family":"de Kleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"van Minnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Eden","family":"Evins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2015.09.007_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1101\/lm.78204","article-title":"Facilitation of fear extinction by D-cycloserine: Theoretical and clinical implications","volume":"11","author":"Richardson","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-cycloserine on extinction: Translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.npp.1301316","article-title":"Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala","volume":"32","author":"Sotres-Bayon","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2007.02.021","article-title":"Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex","volume":"53","author":"Burgos-Robles","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.biopsych.2005.10.012","article-title":"Brain mechanisms of fear extinction: Historical perspectives on the contribution of prefrontal cortex","volume":"60","author":"Sotres-Bayon","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nlm.2013.12.009","article-title":"Opposing effects of D-cycloserine on fear despite a common extinction duration: Interactions between brain regions and behavior","volume":"113","author":"Bolkan","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pnpbp.2013.02.017","article-title":"The effects of intra-hippocampal microinfusion of D-cycloserine on fear extinction, and the expression of NMDA receptor subunit NR2B and neurogenesis in the hippocampus in rats","volume":"44","author":"Ren","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1101\/lm.2070111","article-title":"Medial prefrontal cortex activation facilitates re-extinction of fear in rats","volume":"18","author":"Chang","year":"2011","journal-title":"Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","article-title":"Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder","volume":"67","author":"Otto","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.11r07356","article-title":"D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: A meta-analysis","volume":"73","author":"Bontempo","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib16","doi-asserted-by":"crossref","first-page":"e93519","DOI":"10.1371\/journal.pone.0093519","article-title":"Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopsych.2015.09.007_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jpsychires.2012.05.006","article-title":"A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder","volume":"46","author":"Litz","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00213-011-2571-2","article-title":"Cue exposure and response prevention with heavy smokers: A laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias","volume":"221","author":"Kamboj","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00213-011-2592-x","article-title":"A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals","volume":"226","author":"Price","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jpsychires.2013.06.020","article-title":"D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions","volume":"47","author":"Smits","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopsych.2012.12.009","article-title":"D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: Evidence from the treatment of height phobia","volume":"73","author":"Smits","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1521\/ijct.2009.2.2.160","article-title":"Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review","volume":"2","author":"Hofmann","year":"2009","journal-title":"Int J Cogn Ther"},{"key":"10.1016\/j.biopsych.2015.09.007_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-7-18","article-title":"Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: A systematic review","volume":"7","author":"Watanabe","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/bjp.188.4.305","article-title":"Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review","volume":"188","author":"Furukawa","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1468-2850.2010.01198.x","article-title":"Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: Medication effects, glucocorticoids, and attenuated treatment outcomes","volume":"17","author":"Otto","year":"2010","journal-title":"Clin Psychol Sci Pract"},{"key":"10.1016\/j.biopsych.2015.09.007_bib26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopsych.2012.10.012","article-title":"Chronic antidepressant treatment impairs the acquisition of fear extinction","volume":"73","author":"Burghardt","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1523\/JNEUROSCI.12-03-00854.1992","article-title":"Extinction of fear-potentiated startle: Blockade by infusion of an NMDA antagonist into the amygdala","volume":"12","author":"Falls","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2015.09.007_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1092852900020526","article-title":"Clinical perspectives on the combination of d-cycloserine and CBT for the treatment of anxiety disorders","volume":"12","author":"Otto","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.biopsych.2015.09.007_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(94)90687-4","article-title":"Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention","volume":"257","author":"Quartermain","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2015.09.007_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.biopsych.2007.04.010","article-title":"Effects of D-cycloserine on extinction: Consequences of prior exposure to imipramine","volume":"62","author":"Werner-Seidler","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib31","series-title":"Cognitive Behavior Therapy for Social Anxiety Disorder: Evidence-Based and Disorder-Specific Treatment Techniques","author":"Hofmann","year":"2008"},{"key":"10.1016\/j.biopsych.2015.09.007_bib32","series-title":"Managing Social Anxiety: A Cognitive-Behavioral Therapy Approach, Therapist Guide","author":"Hope","year":"2010"},{"key":"10.1016\/j.biopsych.2015.09.007_bib33","series-title":"Stopping Anxiety Medication (Therapist Guide)","author":"Otto","year":"2009"},{"key":"10.1016\/j.biopsych.2015.09.007_bib34","series-title":"Mastery of Your Anxiety and Panic: Therapist Guide","author":"Barlow","year":"2006"},{"key":"10.1016\/j.biopsych.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive-compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine","volume":"48","author":"Chasson","year":"2010","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2013.12070974","article-title":"D-cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder","volume":"170","author":"Hofmann","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib39","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpsychires.2011.01.020","article-title":"D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial","volume":"45","author":"Siegmund","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/da.21910","article-title":"Five sessions and counting: Considering ultra-brief treatment for panic disorder","volume":"29","author":"Otto","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2015.09.007_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopsych.2012.02.033","article-title":"A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder","volume":"71","author":"de Kleine","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cbpra.2011.05.002","article-title":"D-cycloserine for treatment nonresponders with obsessive-compulsive disorder: A case report","volume":"19","author":"Norberg","year":"2012","journal-title":"Cogn Behav Pract"},{"key":"10.1016\/j.biopsych.2015.09.007_bib43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/da.22132","article-title":"Difficult-to-treat pediatric obsessive-compulsive disorder: Feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy","volume":"30","author":"Farrell","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2015.09.007_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.beth.2013.12.012","article-title":"De novo fear conditioning across diagnostic groups in the affective disorders: Evidence for learning impairments","volume":"45","author":"Otto","year":"2014","journal-title":"Behav Ther"},{"key":"10.1016\/j.biopsych.2015.09.007_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/da.22353","article-title":"Updated meta-analysis of classical fear conditioning in the anxiety disorders","volume":"32","author":"Duits","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2015.09.007_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1037\/a0027695","article-title":"Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson\u2019s disease","volume":"80","author":"Dobkin","year":"2012","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.biopsych.2015.09.007_bib47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/JGP.0b013e31803c550d","article-title":"Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder","volume":"15","author":"Caudle","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.07.002","article-title":"Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder","volume":"39","author":"D\u2019Alcante","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nlm.2006.12.010","article-title":"Effects of D-cycloserine on extinction of learned fear to an olfactory cue","volume":"87","author":"Weber","year":"2007","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.nlm.2008.07.003","article-title":"D-cycloserine facilitates context-specific fear extinction learning","volume":"90","author":"Bouton","year":"2008","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","article-title":"Yohimbine enhancement of exposure therapy for social anxiety disorder: A randomized controlled trial","volume":"75","author":"Smits","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1176\/appi.ajp.2014.13101407","article-title":"Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia","volume":"171","author":"Telch","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib53","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1523\/JNEUROSCI.2466-06.2006","article-title":"Reconsolidation and extinction of conditioned fear: Inhibition and potentiation","volume":"26","author":"Lee","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2015.09.007_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cercor\/bhn076","article-title":"The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans","volume":"19","author":"Kalisch","year":"2009","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2015.09.007_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/da.22257","article-title":"D-cycloserine for treating anxiety disorders: Making good exposures better and bad exposures worse","volume":"31","author":"Hofmann","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2015.09.007_bib56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans","volume":"171","author":"Rothbaum","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.nlm.2005.01.001","article-title":"Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats","volume":"83","author":"Parnas","year":"2005","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.biopsych.2015.09.007_bib58","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D\u2019Souza","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpsychires.2012.09.024","article-title":"Augmentation of exposure therapy with post-session administration of D-cycloserine","volume":"47","author":"Tart","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/bjp.bp.113.126284","article-title":"Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: Pilot randomised controlled trial","volume":"204","author":"Mataix-Cols","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cct.2015.06.015","article-title":"Dose timing of d-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale","volume":"43","author":"Hofmann","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.biopsych.2015.09.007_bib62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamapsychiatry.2015.0546","article-title":"D-Cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: A randomized clinical trial","volume":"72","author":"Andersson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.2009.139","article-title":"D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning","volume":"35","author":"Nic Dhonnchadha","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2015.09.007_bib64","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/syn.20922","article-title":"D-cycloserine facilitates extinction of cocaine self-administration in rats","volume":"65","author":"Thanos","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2015.09.007_bib65","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1280-y","article-title":"The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement","volume":"202","author":"Paolone","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib66","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biopsych.2012.02.030","article-title":"D-cycloserine effects on extinction of conditioned responses to drug-related cues","volume":"71","author":"Myers","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2009.04.023","article-title":"D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation","volume":"104","author":"Santa Ana","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2015.09.007_bib68","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.addbeh.2012.03.022","article-title":"Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers","volume":"38","author":"Yoon","year":"2013","journal-title":"Addict Behav"},{"key":"10.1016\/j.biopsych.2015.09.007_bib69","unstructured":"Physicians\u2019 Desk Reference Staff (2006): Physicians\u2019 Desk Reference 2006: Guide to Drug Interactions, Side Effects, and Indications. Montvale, NJ: Thompson Physicians\u2019 Desk Reference."},{"key":"10.1016\/j.biopsych.2015.09.007_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-011-2199-2","article-title":"A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects","volume":"216","author":"Watson","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00952990.2011.600396","article-title":"Effects of D-cycloserine on craving to alcohol cues in problem drinkers: Preliminary findings","volume":"38","author":"Hofmann","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.biopsych.2015.09.007_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00213-011-2254-z","article-title":"Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: A laboratory study of the effects of D-cycloserine in heavy drinkers","volume":"217","author":"Kamboj","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib73","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00213-015-3882-5","article-title":"Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: A randomized placebo-controlled trial","volume":"232","author":"Kiefer","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2015.09.007_bib74","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1038\/tp.2015.41","article-title":"D-cycloserine to enhance extinction of cue-elicited craving for alcohol: A translational approach","volume":"5","author":"MacKillop","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/eat.22214","article-title":"Confronting fear using exposure and response prevention for anorexia nervosa: A randomized controlled pilot study","volume":"47","author":"Steinglass","year":"2014","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.biopsych.2015.09.007_bib76","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.4088\/JCP.14m09299","article-title":"D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: A pilot randomized controlled trial","volume":"76","author":"Levinson","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(92)90709-D","article-title":"Effect on memory processing by D-cycloserine, an agonist of the NMDA\/glycine receptor","volume":"221","author":"Flood","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2015.09.007_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0091-3057(89)90571-6","article-title":"D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats","volume":"34","author":"Monahan","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2015.09.007_bib79","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/359638a0","article-title":"Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine","volume":"359","author":"Thompson","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2015.09.007_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000172620","article-title":"Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants","volume":"78","author":"Otto","year":"2009","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.biopsych.2015.09.007_bib81","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.biopsych.2010.01.022","article-title":"The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans","volume":"67","author":"Onur","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib82","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib83","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.brat.2006.07.005","article-title":"A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans","volume":"45","author":"Guastella","year":"2007","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2015.09.007_bib84","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0269881111431624","article-title":"Testing the effects of \u03949-THC and D-cycloserine on extinction of conditioned fear in humans","volume":"26","author":"Klumpers","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2015.09.007_bib85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.biopsych.2009.04.017","article-title":"D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms","volume":"66","author":"Grillon","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib86","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-cycloserine does not enhance exposure\u2013response prevention therapy in obsessive\u2013compulsive disorder","volume":"22","author":"Storch","year":"2007","journal-title":"Int Clin Psychopharm"},{"key":"10.1016\/j.biopsych.2015.09.007_bib87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib88","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: Evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine","volume":"48","author":"Chasson","year":"2010","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2015.09.007_bib89","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.11m07564","article-title":"Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: A randomized pilot study","volume":"73","author":"Nave","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2015.09.007_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2011.05.029","article-title":"D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia","volume":"131","author":"Gottlieb","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2015.09.007_bib91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.schres.2014.01.016","article-title":"d-Cycloserine augmentation of cognitive remediation in schizophrenia","volume":"153","author":"Cain","year":"2014","journal-title":"Schizophr Res"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322315007672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322315007672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:32:53Z","timestamp":1567211573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322315007672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0006322315007672"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2015.09.007","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}